Combating sinus, throat, and blood infections with xylitol delivered in the mouth

• US 20070293587A1
• Filed: 08/24/2007
• Published: 12/20/2007
• Est. Priority Date: 05/23/2006
• Status: Abandoned Application

• Current Assignee: Jeffrey Haley
• Original Assignee: Jeffrey Haley
• Inventors: Haley, Jeffrey
• Application Number:
  US11/895,441
• Publication Number:
  US 20070293587A1
• Time in Patent Office: Days
• US Class Current: 514/738
• CPC Class Codes: A61K 31/45 having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
• CPC Class Codes: A61P 11/02 Nasal agents, e.g. decongestants
• CPC Class Codes: A61P 11/04 for throat disorders
• CPC Class Codes: A61P 19/02 for joint disorders, e.g. arthritis, arthrosis
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system

Abstract

A method of suppressing bacteria that cause infections of the throat, sinuses, heart and arteries, and joints (arthritis) by delivering xylitol in a human mouth. The method is effective with troches of pure xylitol or with xylitol chewing gum or liquid, provided sufficient quantities of xylitol are delivered. Streptococcus mutans and Staphylococcus aureus in the blood are important contributors to plaque in arteries and on heart valves and bacterial arthritis. For people whose blood is not already infected with significant levels of these bacteria, every day use of xylitol sufficient to suppress these bacteria in the oral cavity will reduce their risk of subsequent cardiovascular disease, arthritis, and sinus infections. Strep throat is a common throat infection caused by Streptococcus pyogenes. Frequent bathing with xylitol, such as from time release in the mouth, will speed recovery from strep throat.

Claims

1. A method for combating sinus infections, comprising:

(a) providing dissolving mouth delivery objects comprising xylitol; and

(b) instructing consumers of the objects to place an object in a mouth and keep it there until the xylitol in the object is dissolved to reduce their risk of sinus infections.

2. The method of claim 1 wherein the objects are troches that, when exposed to saliva in a human mouth, on average, release xylitol molecules more slowly than a troche of greater than 98% purity xylitol

3. The method of claim 2 wherein the dissolution time of the troches in a human mouth is, on average, more than 25 minutes.

4. The method of claim 1 wherein the troches further comprise a composition of predominantly solid phase xylitol molecules with a reduced rate of dissolution in saliva, comprising crystallized xylitol molecules intermixed with substantial amounts of molecules of hydrophilic gums that swell when exposed to water.

5. The method of claim 1 wherein the objects comprise chewing gum.

6. A method for combating cardiovascular disease, comprising:

(a) providing dissolving mouth delivery objects comprising xylitol; and

(b) instructing consumers of the objects to place an object in a mouth and keep it there until the xylitol in the object is dissolved to reduce their risk of cardiovascular disease.

7. The method of claim 6 wherein the objects are troches that, when exposed to saliva in a human mouth, on average, release xylitol molecules more slowly than a troche of greater than 98% purity xylitol.

8. The method of claim 7 wherein the dissolution time of the troches in a human mouth is, on average, more than 25 minutes.

9. The method of claim 8 wherein the troches further comprise a composition of predominantly solid phase xylitol molecules with a reduced rate of dissolution in saliva, comprising crystallized xylitol molecules intermixed with substantial amounts of molecules of hydrophilic gums that swell when exposed to water.

10. The method of claim 6 wherein the objects comprise chewing gum.

11. A method for combating throat infections, comprising:

(a) providing dissolving mouth delivery objects comprising therapeutic amounts of xylitol; and

(b) instructing consumers of the objects to place an object in a mouth and keep it there until the xylitol in the object is released to treat their throat infections.

12. The method of claim 11 wherein the objects are troches that, when exposed to saliva in a human mouth, on average, release xylitol molecules more slowly than a troche of greater than 98% purity xylitol

13. The method of claim 12 wherein the dissolution time of the troches in a human mouth is, on average, more than 25 minutes.

14. The method of claim 13 wherein the troches further comprise a composition of predominantly solid phase xylitol molecules with a reduced rate of dissolution in saliva, comprising crystallized xylitol molecules intermixed with substantial amounts of molecules of hydrophilic gums that swell when exposed to water.

15. The method of claim 11 wherein the objects comprise chewing gum.

16. A method for combating arthritis, comprising:

(a) providing dissolving mouth delivery objects comprising xylitol; and

(b) instructing consumers of the objects to place an object in a mouth and keep it there until the xylitol in the object is released to reduce their risk of arthritis.

17. The method of claim 16 wherein the objects are troches that, when exposed to saliva in a human mouth, on average, release xylitol molecules more slowly than a troche of greater than 98% purity xylitol.

18. The method of claim 17 wherein the dissolution time of the troches in a human mouth is, on average, more than 25 minutes.

19. The method of claim 18 wherein the troches further comprise a composition of predominantly solid phase xylitol molecules with a reduced rate of dissolution in saliva, comprising crystallized xylitol molecules intermixed with substantial amounts of molecules of hydrophilic gums that swell when exposed to water.

20. The method of claim 16 wherein the objects comprise chewing gum.